Skip to main content
See every side of every news story
Published loading...Updated

ACLU sues FDA for records on abortion pill review

  • The ACLU has sued the FDA for not complying with the Freedom of Information Act regarding its review of the abortion pill mifepristone, calling for transparency in its proceedings.
  • The lawsuit demands compliance with the Freedom of Information Act following previous requests that the FDA did not address.
  • Mifepristone, the most common medicine for abortions, accounted for 1 in 4 abortions in 2023 and is deemed safe compared to other medications.
  • Rachel Reeves emphasized the need for transparency, stating that the current administration fails to provide available information about medication abortion.
Insights by Ground AI

15 Articles

Pennsylvania Capital-StarPennsylvania Capital-Star
+12 Reposted by 12 other sources
Lean Left

FDA’s abortion-pill safety review under growing scrutiny

U.S. Health and Human Services Secretary Robert F. Kennedy Jr., shown here in September, cited a white paper funded and self-published without peer review by anti-abortion groups as grounds for federal scrutiny of a key abortion medication’s safety. (Photo by Andrew Harnik/Getty Images)The U.S. Food and Drug Administration is facing increasing pressure from abortion opponents and advocates over how it regulates a drug that has become central to …

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 92% of the sources lean Left
92% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Alabama Political Reporter broke the news in on Monday, November 17, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal